BioCentury
ARTICLE | Clinical News

Plegridy peginterferon beta-1a regulatory update

May 27, 2013 7:00 AM UTC

Biogen Idec submitted a BLA to FDA for Plegridy peginterferon beta-1a to treat relapsing forms of multiple sclerosis (MS). The company said it expects to submit MAA to EMA "in the coming weeks." The p...